US Stock MarketDetailed Quotes

BIAF bioAffinity Technologies

Watchlist
  • 2.910
  • +0.080+2.83%
Close Apr 17 16:00 ET
  • 2.960
  • +0.050+1.72%
Post 18:56 ET
33.51MMarket Cap-3197P/E (TTM)

About bioAffinity Technologies Company

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Company Profile

SymbolBIAF
Company NamebioAffinity Technologies
Listing DateSep 1, 2022
Issue Price6.12
Founded2014
CEOMs. Maria Zannes, J.D.
MarketNASDAQ
Employees75
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address22211 West Interstate 10,Suite 1206
CitySan Antonio
ProvinceTexas
CountryUnited States of America
Zip Code78257
Phone1-210-698-5334
Websitehttp://www.bioaffinitytech.com

Company Executives

  • Name
  • Position
  • Salary
  • Maria Zannes, J.D.
  • President, Chief Executive Officer and Director
  • 424.17K
  • Dr. Vivienne Rebel, M.D.
  • Executive Vice President, Chief Science and Medical Officer
  • 252.31K
  • Xavier Trinidad Reveles
  • Chief Operating Officer
  • --
  • Michael Dougherty
  • Chief Financial Officer and Principal Accounting Officer
  • 338.92K
  • Timothy P. Zannes, J.D.
  • Executive Vice President, Secretary and General Counsel
  • --
  • Steven Girgenti
  • Executive Chairman of the Board
  • 248.75K
  • Dr. Jamie Platt, PhD
  • Director
  • --
  • Roby P. Joyce, M.D.
  • Director
  • 25.00K
  • Stuart Diamond
  • Independent Director
  • 105.00K
  • Gary Rubin
  • Independent Director
  • 102.47K
  • Peter S. Knight
  • Independent Director
  • 102.50K
  • Robert A. Anderson
  • Independent Director
  • 100.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg